Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate CancerHoward I. Scher, Ryan Dittamore|JAMA Oncology|2016Cited by 635
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY StudyAndrew J. Armstrong, Daniel J. George, Susan Halabi et al.|Journal of Clinical Oncology|2019Cited by 364
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutationsFatima Karzai, William L. Dahut, Anna Couvillon et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 312